How We Got Here
Developing PhotoMed’s Therapy
PhotoMed’s team began developing its then experimental therapy in 2000. Testing in clinics and studies focused on finding who might benefit and how quickly. The studies welcomed people unexpected to improve. Many improved! Skip to examples.
The recorded rapid physiological responses were not predicted in textbooks on pain and neuroscience. PhotoMed’s skeptical team recorded events in real-time in the hope of finding an error while improving PhotoMed’s therapy. The team added modules to the evolving Rapid Discovery System™ to capture progress of multiple impairments in the same person.
Practitioners in small clinics used feedback from the imaging system to support their adjustment of therapy by different wavelengths. For example, therapy for cold limbs was only needed long enough to prompt the first observed warming. A neurologist observed a pupillary response at the moment when warming begins. Observed phenomena suggest follow-on studies.
Physiologic Responses Tell Important Stories
People who experienced profoundly cold fingers and toes demonstrated that their limbs could rapidly return toward normal within a few minutes. Warming responses had been observed, although rarely, for decades using red and IR wavelengths.
Practitioners appreciated PhotoMed’s improved therapeutic efficiency from the ability to adjust and vary wavelengths. Recorded thermal imaging helped to identify which wavelengths might be most productive for a first attempt.
Today, practitioners can use the Rapid Discovery System™ to record and share the responses with their patients. PhotoMed’s tools are available for researchers find out how this exciting response works.
Volunteers with unresponsive pain and impairment contributed the first-ever comparisons of effects of different wavelengths. Practitioners adjusted therapy by different wavelengths until they achieved the response thought to mark the return toward normal function. The comparisons were for practical, rather than scientific, reasons.
Recordings from 18-years of unexpected events reveal possible associations among disorders based upon the innate impairments. Warming responses have been reported for decades as isolated events. Recordings of such events invite and can help answer new questions.
This example illustrates the testing of different wavelengths aimed to prompt warming. The effective wavelength cannot be known in advance because the response is not limited to any single wavelength. Access to all wavelengths increases the likelihood of success. PhotoMed’s team did not recognize the significance of synchronized warming for more than a decade after it was first noticed. Contrary to common notions, synchronized warming suggests that everything is working correctly except the command somewhere deep in the brain. Note that for some people, the experience of painfully persistent coldness is independent of the actual temperatures.
Opening New Areas of Study and Care
18-years of recorded data reveal the return toward normal function for previously unresponsive pain and impairments.
The recorded data invite and help to answer new questions. The Rapid Discovery System can save time and money making the next big discoveries. Contact PhotoMed to discuss your project needs.
The studies welcomed volunteers unexpected to respond to the therapy. Their outcomes led to the discovery that people with unresponsive pain and impairments frequently respond to PhotoMed’s therapy. Responses to any fixed wavelengths are rare for people with the “nothing works” disorders.
Additionally, fixed wavelengths and other therapies have a long history of accelerating responsive disorders. Access to all visible wavelengths increases the likelihood of improvement.
The recordings will return value for foreseeable future as seeds for future research and the fact that the examples originated during development of PhotoMed’s therapy.
The Rapid Discovery System™ provides a modular platform for continuing to collect data using the PDS400 to maintain association with 18-years of field data. PhotoMed’s updated version of the Rapid Discovery System™ tracks the practitioners choices as they make second-by-second adjustments to therapy.
Here are some of the impairments that responded to PhotoMed's therapy:
The National Institutes of Health (NIH) declare that “chronic pain is considered a disease itself”. Do the following apparently disparate disorders share a common factor that might help identify the “disease”? The responses reveal the appropriate physiological return toward normal function. Should the responses be surprising? (Most people’s pain and impairments return to normal before the “chronic” clock begins.)
How long the benefit persists after therapy ends suggests whether healing had otherwise completed before therapy began.
Loss of sensation in fingers or toes
Diabetic peripheral neuropathy (DPN)
Complex regional pain syndrome (CRPS or RSD)
Neuropathy from other causes, such as stroke or spinal cord injury
Sympathetically mediated (or maintained) pain, especially people who have benefited from a sympathetic nerve block or sympathectomy
Post-herpetic pain (shingles)
Phantom limb pain
Loss of grip strength and movement
Loss of movement after stroke (therapy helps overcome acquired non-use)
Carpal tunnel syndrome
Muscle imbalance, i.e. scoliosis
Loss of coordination in gait & swallowing, and choreic movements from Huntington’s disease
Restart non-healing wounds at any stage
Accelerate slow-healing wounds
Diabetic foot ulcers and loss of sensation
Venous stasis ulcers, bed sores
Improve scars, keloids
Abnormally cold or hot hands, with or without pain
Thermoregulation, gut, bowel, and bladder function after spinal cord injury
Complex regional pain syndrome (CRPS or RSD)
Please Tell Us Your Story
Please share your story about your experience in a study using PhotoMed’s therapy and any improvements. Your follow-up information helps us understand how our therapy works for different disorders. You are welcome to ask questions through this contact form.